<DOC>
	<DOCNO>NCT01223001</DOCNO>
	<brief_summary>The primary objective study compare efficacy duloxetine 60 mg mouth daily placebo prevention depression associate mild/moderate traumatic brain injury enhance cognitive function .</brief_summary>
	<brief_title>Feasibility Study Duloxetine Treatment Depression Patients With Traumatic Brain Injury</brief_title>
	<detailed_description>The primary objective study compare efficacy duloxetine 60 mg mouth daily placebo prevention depression associate mild/moderate traumatic brain injury enhance cognitive function . Research explore use selective serotonin reuptake inhibitor treatment post-traumatic depression generally validate approach ( Horsfield et al. , 2002 ) . However , literature suggest serotonin/norepinephrine reuptake inhibitor duloxetine may effective treatment depression .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Study participant 40 men woman age 18 75 provide appropriate consent agreeable study requirement Diagnosed mild moderate traumatic brain injury define initial Mayo Traumatic Brain Injury Severity Scale Have memory impairment define Hopkins Verbal Learning Test delay recall score fall less equal 1.5 standard deviation mean . Refusal give inform consent A previous Central Nervous System illness injury , include seizure exhibit residual symptom . Current posttraumatic seizure disorder A previous diagnosis psychotic disorder Current previous ( last 6 month ) treatment history alcohol substance dependency Medications affect noradrenergic dopaminergic system , alphaadrenergic antihypertensive , antidepressant , phenobarbital , Monoamine oxidase inhibitor ( MAOI ) , schedule benzodiazepine , psychoactive herbal supplement ( include Kava , St. John 's wort ) , nutritional supplement within least 14 day discontinue treatment medication supplement . A known suicide risk A pregnant breastfeed woman Uncontrolled narrowangle glaucoma Serious and/or unstable medical comorbidity ( e.g. , AIDS , cancer , history uncontrolled hypertension cardiovascular disease ) psychological condition , clinically significant laboratory abnormality opinion investigator would compromise participation study likely lead hospitalization course study Liver enzymes &gt; 1.5 time upper limit normal Patients endstage renal disease ( require dialysis ) severe renal impairment Known hypersensitivity duloxetine inactive ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Depression</keyword>
	<keyword>Traumatic brain injury</keyword>
	<keyword>Duloxetine</keyword>
	<keyword>Cymbalta</keyword>
	<keyword>impaired cognitive function</keyword>
</DOC>